View Older Stories View More Recent Stories

Feb 14, 2022 04:35PM Form SC 13G/A Xilio Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:35PM Form SC 13G/A Viridian Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:35PM Form SC 13G/A 5:01 Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:35PM Form SC 13G/A Silverback Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:35PM Form SC 13G/A scPharmaceuticals Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:35PM Form SC 13G/A Cyteir Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:26PM Form SC 13G/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:26PM Form SC 13G/A MACROGENICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:26PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:26PM Form SC 13G/A OTONOMY, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:26PM Form SC 13G Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:26PM Form SC 13G/A Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:25PM Form SC 13G/A Tango Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:25PM Form SC 13G/A BCLS Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A Pyxis Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A PhaseBio Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:21PM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Milestone Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Olema Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A CytomX Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Frazier Lifesciences Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Nautilus Biotechnology, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A Akouos, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2022 04:20PM Form SC 13G/A NOVAVAX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2022 09:00AM Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
Feb 10, 2022 07:30AM Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multip
Feb 9, 2022 08:00AM AavantiBio Announces Formation of Scientific Advisory Board
Feb 9, 2022 07:00AM Ventus Therapeutics Closes $140 Million Series C Financing
Feb 4, 2022 08:00AM Hemab Therapeutics Announces First Drug Candidate: HMB-001, a Novel Bispecific Antibody with Potential for Treatment of Rare Bleeding Disorders
Jan 25, 2022 08:00AM Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform
Jan 19, 2022 08:00AM PepGen Appoints Laurie Keating as Chair of Board of Directors
Jan 12, 2022 06:45AM TCR² Therapeutics Announces Experienced Biotech Executive Rosemary Harrison as Chief Business and Strategy Officer
Jan 12, 2022 06:45AM TCR² Therapeutics Announces Experienced Biotech Executive Rosemary Harrison as Chief Business and Strategy Officer
Jan 10, 2022 05:01PM Form SC 13G PARDES BIOSCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 7, 2022 07:00AM AN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program
Jan 6, 2022 08:00AM Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
Jan 5, 2022 08:00AM Hemab Therapeutics Appoints John Maraganore as Chair of Board of Directors and Welcomes New Additions to Board and Leadership Team
Jan 4, 2022 08:00AM AavantiBio to Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 27, 2021 07:00AM Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19
Dec 22, 2021 04:33PM Form SC 13G BELLUS Health Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 20, 2021 04:34PM Form SC 13G RELMADA THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 16, 2021 08:03AM Tasso Secures $100M in Series B Financing
View More Recent Stories View Older Stories